AdvaMed continues pressure on White House to exempt devices from tariffs

Amid the whirlwind of tariff news, AdvaMed and other healthcare groups have pleaded for the Trump administration to exempt medical devices and critical supplies.

By Ricky Zipp • April 8, 2025

J&J starts IVL trial in ‘difficult-to-cross’ coronary arteries

The device is differentiated from other Shockwave products, and rival catheters from Abbott and Boston Scientific, because it emits waves from its tip.

By Nick Paul Taylor • April 8, 2025

Explore the Trendline➔

Medical device industry continues to turn to AI

While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

By MedTech Dive staff

Trump threatens 50% tariff on China if retaliatory duties stay

The president said China has until Tuesday to back off from its plan for 34% tariffs on U.S. imports.

By Max Garland • April 8, 2025

China probes US-made CT tubes after Trump hikes tariffs

The investigation indicates that China will likely favor local medtech companies over foreign competition amid international economic tensions, a J.P. Morgan analyst said.

By Elise Reuter • April 7, 2025

Enovis appoints Damien McDonald as CEO

McDonald, who is set to start as CEO on May 12, is joining a business that has expanded quickly in the orthopedic reconstruction sector.

By Nick Paul Taylor • April 7, 2025

A ‘wobbly’ moment in business: Manufacturers face life under Trump’s tariffs

Companies are pushing to be more agile and flexible as the Trump administration’s baseline 10% tariff takes effect, but challenges loom ahead.

By Kate Magill • April 4, 2025

Tariffs send healthcare industry into ‘unchartered waters’

Provider groups and health systems warn tariffs will test healthcare’s fragile supply chain. Wall Street, meanwhile, said medtech businesses will face pressure, particularly diabetes tech firms.

By Susanna Vogel , Susan Kelly • April 4, 2025

China readies 34% tariff on US imports starting April 10

The country’s retaliation against President Donald Trump’s trade policies builds upon previously announced duties.

By Max Garland • April 4, 2025

Eargo, Hearx merge into one OTC hearing aid firm, receive $100M boost

Hearx, the maker of Lexie hearing aids, and Eargo competed for the OTC hearing aid market created by the FDA in 2022.

By Nick Paul Taylor • April 3, 2025

Dr. Oz confirmed to lead CMS

Dr. Mehmet Oz, a physician and TV personality, will lead the agency during a turbulent time for federal health programs as the HHS lays off thousands of staffers and Republicans float potential cuts to Medicaid.

By Emily Olsen • Updated April 4, 2025

AdvaMed repeats call for tariff exemption as new levies threaten healthcare supply chain

Lobby groups like AdvaMed and the American Hospital Association have so far failed to get medical devices and critical supplies carved out from the Trump administration’s tariffs.

By Susan Kelly , Susanna Vogel • April 3, 2025

Boston Scientific’s Farapulse matches Medtronic cryoablation in trial

Atrial tachyarrhythmia recurred in 39 patients treated with Boston Scientific’s Farapulse PFA device, while 53 people had recurrence in the Medtronic cryoablation group.

By Nick Paul Taylor • April 3, 2025

Trump installs 10% baseline tariff, country-specific duties

The president said he will levy import taxes on China, Japan and others equal to half of what they charge the U.S. based on White House calculations.

By Philip Neuffer • April 3, 2025

CMR Surgical secures $200M for US robot rollout

Launching Versius in the U.S. is a top priority for CMR, which claims the system is the second most adopted soft tissue robot globally.

By Susan Kelly • April 2, 2025

‘Just goodbyes and crying’: CDRH hit in HHS mass layoffs

Teams working on communications and policy were cut from the agency on Tuesday, according to multiple FDA workers interviewed by MedTech Dive.

By Elise Reuter • April 2, 2025

3 takeaways from ACC 2025

Medtronic, Abbott and Boston Scientific had updates on their devices used in heart valve disease treatment at the event.

By Susan Kelly • April 2, 2025

Texas judge overturns FDA’s lab developed test regulation, siding with industry groups

The judge vacated the FDA’s final rule, which was strongly opposed by the laboratory industry, and remanded the matter to HHS Secretary Robert F. Kennedy Jr.

By Susan Kelly • April 1, 2025

Bausch + Lomb recalls Envista intraocular lenses over safety risks

J.P. Morgan analysts said it was too early to discuss the financial impact of the recall, but estimated that $70 million to $90 million of revenue could be at risk this year.

By Nick Paul Taylor • March 31, 2025

Tandem eyes Medicare coverage expansion for Type 2

CMO Jordan Pinsker said Tandem hopes to expand Medicare coverage of its automated insulin delivery systems using new data shared at ATTD.

By Elise Reuter • March 31, 2025

J&J launches energy generator compatible with Ottava robot

Johnson & Johnson said the Dualto energy system’s design allows for up to 46% less footprint than separate generators.

By Nick Paul Taylor • March 28, 2025

‘Everything is word of mouth’: HHS employees face uncertainty in looming Trump layoffs

Many HHS department heads and employees were unaware of plans to fire some 10,000 employees until they were announced Thursday, sources said.

By Sydney Halleman , Ned Pagliarulo , Rebecca Pifer • March 28, 2025

Abbott snags early CE mark for Volt PFA device

With PFA becoming physicians’ preferred ablation method for treating AFib, Abbott is pushing to catch up with rival systems already on the market.

By Susan Kelly • March 28, 2025

Newly public Beta Bionics reports sales surge; Dexcom hires CCO

Sales of Beta Bionics insulin pumps spiked 145% in the fourth quarter behind solid new patient starts. Elsewhere, former Masimo exec Jon Coleman joined Dexcom, and Sibionics’ CGM earned the CE mark.

By Nick Paul Taylor • March 28, 2025

Dexcom rejects claims of unauthorized device changes in FDA warning letter

A company spokesperson said Dexcom plans to resolve the agency’s concerns but stated no design changes were made to its glucose sensors.

By Elise Reuter • March 27, 2025

HHS to cut 10,000 employees in major restructuring under RFK Jr.

Advamed CEO Scott Whitaker said Thursday that “any reduction in force should be accompanied by policy and regulatory improvements that encourage innovation in medtech.”

By Ned Pagliarulo , Rebecca Pifer , Ricky Zipp • Updated March 27, 2025